McKesson Corporation
McKesson Appoints New CFO Following Retirement of Britt J. Vitalone
Summary
McKesson Corporation announced on March 3, 2026, the retirement of its current Executive Vice President and Chief Financial Officer, Britt J. Vitalone, effective May 28, 2026. Following his retirement, Kenny K. Cheung will take over as the new CFO, effective May 29, 2026. Cheung, previously the Executive Vice President and CFO of Sysco Corporation, brings extensive experience in financial planning and analysis, accounting, audit, tax, and corporate finance. Additionally, Vitalone will serve as a non-employee advisor to the company starting July 2, 2026, under an Advisor Agreement.
Profitelligence Alerts
Get alerts for MCK
Be first to know when McKesson Corporation files with the SEC.
Filing Categories
Advertisement
About McKesson Corporation
McKesson Corporation is a leading healthcare services and information technology company. It plays a crucial role in the distribution of pharmaceuticals and medical products. The primary function of McKesson is to ensure the efficient delivery of healthcare products to pharmacies, hospitals, and other medical facilities, ensuring that millions of patients have access to the medications they need. It also provides specialized software and automated solutions that enhance operational efficiency in healthcare sectors. McKesson significantly impacts the pharmaceutical and healthcare industries by offering solutions that streamline supply chains and improve patient care. Its services encompass wholesale drug distribution, healthcare IT systems, and pharmacy management. With operations that extend globally, McKesson is integral to maintaining the integrity and reliability of healthcare supply networks. By handling a substantial portion of the pharmaceutical distribution in North America, McKesson Corporation has a vital market presence, emphasizing its importance in shaping healthcare logistics and innovation. Its efforts contribute to advancing healthcare delivery and responding to the evolving demands of the medical industry.
Official SEC Documents
Advertisement